Posts tagged Cytori Therapeutics Inc


Analysts Remain Buyers of 2 Volatile Healthcare Stocks: Cytori Therapeutics Inc (CYTX) and TearLab Corp (TEAR)

Cytori Therapeutics Inc: Should You Catch This Falling Knife? Cytori Therapeutics Inc (NASDAQ:CYTX) shares are crashing …

Read more

Why Cytori Therapeutics Inc (CYTX) Shares Collapsed Today

Monday turned out to be a nightmare for shareholders of Cytori Therapeutics Inc (NASDAQ:CYTX), after …

Read more

Cytori Therapeutics Inc (CYTX) Tumbles To 52-Week Low On Back Of Share Dilution

Cytori Therapeutics Inc (NASDAQ:CYTX) announced the pricing of its underwritten public offering of 8,600,000 of its …

Read more

Maxim Analyst Comments on Cytori Therapeutics Inc Following Azaya Acquisition

Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Cytori Therapeutics Inc (NASDAQ:CYTX) …

Read more

Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Announces Two Year Follow-Up Published on EU Scleroderma Trial

Cytori Therapeutics Inc (NASDAQ:CYTX) announced publication of two-year clinical follow-up of patients treated with a …

Read more

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc Presents Compelling Cell Therapy Results at Annual International Federation of Adipose Therapeutics Conference

Cytori Therapeutics Inc (NASDAQ:CYTX) scientists presented two research papers at the annual meeting of the …

Read more

Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Strengthens Global Intellectual Property Portfolio with Key Patents

Cytori Therapeutics Inc (NASDAQ:CYTX) announced the issuance of a number of key patents that strengthen …

Read more

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma

Cytori Therapeutics Inc (NASDAQ:CYTX) announced that the US FDA Office of Orphan Products Development (OOPD) …

Read more

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc Announces Publication of Cytori Cell Therapy for Combined Radiation and Thermal Injury

Cytori Therapeutics Inc (NASDAQ:CYTX) announced the publication of preclinical safety and efficacy study data using …

Read more

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc Partner Kerastem Completes Enrollment of US Phase II Trial for Early Stage Hair Loss

Cytori Therapeutics Inc (NASDAQ:CYTX) announced that its licensee Kerastem Technologies, LLC, has completed enrollment of STYLE, a …

Read more